This week in Nature: Higgs at 10 – Probing the properties of the most elusive particle in physics. Browse the full issue:
On 4 July 2012, researchers at the Large Hadron Collider made a long-awaited announcement: they had finally obtained evidence that affirmed the existence of the Higgs boson.
In this week’s issue, teams from the two main experiments at the LHC present analyses of all the data collected on the particle since its discovery. The standard model of particle physics predicts that coupling between the Higgs boson and any given particle should be proportional to their mass — the
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
10 Years after the Higgs, Physicists Are Optimistic for More DiscoveriesThe Large Hadron Collider recently reopened after upgrades and is ready to explore new territory
Read more »
All you need to know about the Higgs Boson 'God Particle'Discovered over ten years ago, the Higgs Boson brought us closer to understanding the fundamental forces that underpin the galaxy.
Read more »
Physicists Stunned by Nature in the Wrong Direction: Magnetic Spins That “Freeze” When HeatedPhysicists observed a very strange new type of behavior in a magnetic material when it’s heated up. When the temperature rises, the magnetic spins ‘freeze’ into a static pattern, a phenomenon that normally occurs when the temperature decreases. Their findings were published in Nature Physics today,
Read more »
For America's birthday, Mother Nature gives California a gift: cool temperatures.In a Fourth of July rarity, the weather in Southern California is nearly perfect as temperatures soar across the country.
Read more »
The promise of precision medicine in rheumatology - Nature MedicinePrecision medicine for rheumatic diseases is still in its infancy, but recent advances are enabling comprehensive profiling and mechanistic insights. This Review outlines the progress, promises, and challenges of translating these findings into the clinic.
Read more »
Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study - Nature MedicineIn a phase 2a clinical trial in patients with non-alcoholic steatohepatitis, dual inhibition of sodium-glucose cotransporters 1 and 2 with 150mg of licogliflozin led to reductions in serum alanine aminotranferase levels. Pinnacle_TX
Read more »